Results 161 to 170 of about 41,400 (225)

Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002). [PDF]

Commun Med (Lond)
Yang DL, Qin C, Peng N, Liu SP, Yu YQ, Nong JL, Zeng FJ, Su Z, Yang YY, Yang FQ, Li MJ, Wu MS, Wang XY, Liang YR, Li FX, Chen SC, Lai YC, Pang QQ, Zhong TM, Yan YH, Zhang YY, Ye L, Dong XF, Li WF, Liu J, Yao HB, Wu PS, Mao XS, Ou JJ, Chen YZ, Wang GD, Chen K, Deng ZJ, Su JY, Qiu GG, Liu ZD, Wang JM, Zhang Y, Liang XM, Xiang BD, Ma L, Zhong JH, GUIDANCE investigators.   +42 more
europepmc   +1 more source

Efficacy and safety of DEB-TACE combined with HAIC and donafenib in the treatment of unresectable hepatocellular carcinoma: a dual-center retrospective study. [PDF]

BMC Cancer
Zhang X, Fang X, Wang R, Xiong B, Long J, Guo Q, Chu M, Luo W, Shi S.   +8 more
europepmc   +1 more source

Development of a Research Agenda for the Management of Metastatic Colorectal Cancer: Proceedings from a Multidisciplinary Research Consensus Panel [PDF]

, 2012
Cohen, Steven J., d’Othée, Bertrand Janne, Geschwind, Jean-Francois, Hanna, Nader, Johnson, Matthew S., Kee, Stephen T., Kennedy, Andrew S., Lewandowski, Robert J., Murthy, Ravi, Sofocleous, Constantinos T., Soulen, Michael C., Vauthey, Jean-Nicolas, Venook, Alan P.   +12 more
core   +1 more source

Application of Preoperative Transarterial Chemoembolization Before Hilar Liver Tumour Resection in a Dog. [PDF]

Vet Med Sci
Son H, Jeon S, Kim J, Lee S.
europepmc   +1 more source

3. Transarterial Chemoembolization

Nihon Naika Gakkai Zasshi, 2014
openaire   +2 more sources

Erratum: [Corrigendum] Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. [PDF]

Oncol Lett
Hou X, Xu Q, Yin L, Wang H, Wu J, Liu B, He D, Liu R.   +7 more
europepmc   +1 more source

Efficacy and safety of sintilimab plus a bevacizumab biosimilar combined with transarterial chemoembolization for advanced hepatocellular carcinoma. [PDF]

Medicine (Baltimore)
Yang J, Xu Q, Wu S.
europepmc   +1 more source

Transarterial chemoembolization combined with immunotherapy and targeted therapy as first-line treatment for unresectable and non-metastatic hepatocellular carcinoma: a meta-analysis of phase III trials. [PDF]

Ther Adv Gastroenterol
Wang L, Luo B, Zhao M, Shen J.
europepmc   +1 more source

Performance of Liver Imaging Reporting and Data System (LI-RADS) nonradiation treatment response algorithm version 2024 on magnetic resonance imaging for transarterial chemoembolization plus systemic therapy in hepatocellular carcinoma. [PDF]

Quant Imaging Med Surg
Sheng L, Yang C, Chen Y, Wei H, Yang Y, Chernyak V, Bashir MR, Jiang H, Qu Y, Song B, Ye Z.   +10 more
europepmc   +1 more source

Erratum: Efficacy of transcatheter arterial chemoembolization-based multimodal treatment in patients with neuroendocrine tumors involving the liver. [PDF]

Transl Cancer Res
Editorial Office.
europepmc   +1 more source